Aspire Biopharma Holdings, Inc. Proceeds from Notes Payable
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-08-13
- Aspire Biopharma Holdings, Inc. proceeds from notes payable for the quarter ending 2025-12-31 was $0.00.
- Aspire Biopharma Holdings, Inc. proceeds from notes payable for the quarter ending 2025-09-30 was $0.00.
- Aspire Biopharma Holdings, Inc. proceeds from notes payable for the quarter ending 2025-06-30 was $0.00.
- Aspire Biopharma Holdings, Inc. proceeds from notes payable for the quarter ending 2025-03-31 was $50.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-04-10 | $0.00 derived: sum of 2 quarters · filed 2026-04-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $50.00K S-1/A · filed 2026-04-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $50.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $50.00K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $50.00K 10-Q · filed 2026-05-15 |